Kimberly D Bergan, MOT, OTR/L | |
3607 S Heirloom Dr, Bloomington, IN 47401 | |
(812) 336-2718 | |
Not Available |
Full Name | Kimberly D Bergan |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 3607 S Heirloom Dr, Bloomington, Indiana |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285116657 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 31001986A (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Kimberly D Bergan, MOT, OTR/L 5599 W Redbud Dr, Ellettsville, IN 47429 Ph: (812) 320-0098 | Kimberly D Bergan, MOT, OTR/L 3607 S Heirloom Dr, Bloomington, IN 47401 Ph: (812) 336-2718 |
News Archive
Gender-affirming hormone therapy is the bedrock of medical therapy for many transgender and gender diverse individuals. Some adult transgender individuals decide with their health care provider to start hormone therapy – testosterone for transmasculine people and generally a combination of estrogen and antiandrogens for transfeminine people – specifically for the physical and psychological effects these hormones produce, including changes to the voice, skin, facial and body hair and body composition. However, in the context of the global obesity epidemic, little is known about obesity rates and weight changes in adults treated with gender-affirming hormone therapy.
People exposed to a H1NI strain of influenza A while in utero were significantly more likely to have cardiovascular disease later in life, reveals a new study to be published in Journal of Developmental Origins of Health and Disease on Oct. 1.
A new study describes two promising small molecules that inhibit a host cell factor, called nucleotide binding oligomerization domain-containing protein 2 (NOD2), that inhibits the replication and spread of many arboviruses. This could lead to the development of broad-spectrum antivirals. The study's findings have been published on the preprint server bioRxiv*.
YM BioSciences Inc., today announced the first results of a collaborative program between YM and the National Research Council of Canada's Biotechnology Research Institute (NRC-BRI). Utilizing YM's IntelliMab(TM) technology, the program is designed to generate novel antibodies that target cell surface receptors associated with cancer, uniquely optimized to produce efficacy with reduced toxicities.
MicroDose Therapeutx, Inc. today announced that the first human subject has been dosed in a Phase 1 clinical trial of MDT-637, MicroDose's inhalable small molecule antiviral fusion inhibitor for the treatment of respiratory syncytial virus.
› Verified 4 days ago
Christie Leigh Pace, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2770 S Adams St, Bloomington, IN 47403 Phone: 866-465-5993 | |
Ms. Laurie Susan Allen, OTR CHT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 583 S Clarizz Blvd, Bloomington, IN 47401 Phone: 812-333-2663 Fax: 812-349-9206 | |
Lois Irisa Butcher, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1100 S Curry Pike, Bloomington, IN 47403 Phone: 812-675-4948 | |
Cecilia Wanchic, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 8955 W Rice Rd, Bloomington, IN 47403 Phone: 812-325-9248 | |
Carrie Pepper, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 328 S Woodscrest Dr, Bloomington, IN 47401 Phone: 812-353-5534 | |
Kevin Joseph Kathman, ORT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 583 S Clarizz Blvd, Bloomington, IN 47401 Phone: 812-333-5915 Fax: 812-333-5919 | |
Katie Edwards, MS, OTR Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 2605 E Creeks Edge Dr, Bloomington, IN 47401 Phone: 812-353-3343 Fax: 812-353-3346 |